Twist Bioscience Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Twist Bioscience Corporation (TWST) Tops Q1 EPS by 15c
February 4, 2022 7:33 AM ESTTwist Bioscience Corporation (NASDAQ: TWST) reported Q1 EPS of ($0.91), $0.15 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $42 million versus the consensus estimate of $38.33 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2022 revenue of $189-198 million, versus the... More
